Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease
Mesenchymal stromal cells (MSCs) have been shown to support multiple myeloma (MM) development. Here, MSCs isolated from the bone marrow of MM patients are shown to have altered DNA methylation patterns and a methyltransferase inhibitor reverts MM-associated bone loss and reduces tumour burden in MM...
Enregistré dans:
Auteurs principaux: | Antonio Garcia-Gomez, Tianlu Li, Carlos de la Calle-Fabregat, Javier Rodríguez-Ubreva, Laura Ciudad, Francesc Català-Moll, Gerard Godoy-Tena, Montserrat Martín-Sánchez, Laura San-Segundo, Sandra Muntión, Xabier Morales, Carlos Ortiz-de-Solórzano, Julen Oyarzabal, Edurne San José-Enériz, Manel Esteller, Xabier Agirre, Felipe Prosper, Mercedes Garayoa, Esteban Ballestar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/97c0cd9d38aa419d8042bda6761115e0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
par: Iñigo Apaolaza, et autres
Publié: (2017) -
Epigenetic signatures associated with different levels of differentiation potential in human stem cells.
par: Pablo Aranda, et autres
Publié: (2009) -
Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
par: Amaia Vilas-Zornoza, et autres
Publié: (2011) -
Quantification of miRNA-mRNA interactions.
par: Ander Muniategui, et autres
Publié: (2012) -
Activation-induced cytidine deaminase targets SUV4-20-mediated histone H4K20 trimethylation to class-switch recombination sites
par: Virginia C. Rodríguez-Cortez, et autres
Publié: (2017)